Clinical Social Workers in Valley Springs, CA Accepting Medicare
3 Clinical Social Workers found. Showing 1 - 3
 Ms. Emily Mcclintic Jacobs, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 10 B Vista Del Lago, Suite #3, Valley Springs, CA 95252 Phone: 209-304-2924 Fax: 209-772-2094 |
Christine Lynn Mckeehan, ASW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1931 N Ranchero Rd., Valley Springs, CA 95252 Phone: 209-231-8923 |
 Paul L Symmonds, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1919 Vista Del Lago Dr, Valley Springs, CA 95252 Phone: 208-772-9538 |
News Archive
Researchers reveal how brain-specific microRNA plays key role in causing abnormal brain development
Autism Spectrum Disorders (ASDs) are a group of highly inheritable behavioural disorders that pose major personal and public health concerns. Patients with ASDs have mild to severe communication difficulties, repetitive behaviour and social challenges. Such disorders significantly challenge an individual's ability to conduct daily activities and function normally in society. Currently there are very few medication options that effectively treat ASDs.
The health law and legal challenges: What the future holds
News outlets continue their efforts to handicap the health law's chances as it progresses through the judicial system toward the Supreme Court. Meanwhile, The New York Times reports on a proposal — inspired by such repeal efforts — for a Constitutional amendment that would allow states to overturn federal laws passed by Congress.
Galectin submits GR-MD-02 IND application with FDA for treatment of liver fibrosis
Galectin Therapeutics, the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer, announced today that it submitted an Investigational New Drug (IND) application to the US Food and Drug Administration (FDA) on January 30, 2013.
NeoPharma submits a Phase II protocol to the FDA for its liposome entrapped docetaxel study
NeoPharm, Inc. today announced that it has submitted a Phase II protocol to the FDA for the study of liposome entrapped docetaxel (LE-DT), a novel, proprietary liposomal delivery system of docetaxel, the active ingredient of Taxotere®, for locally advanced or metastatic pancreatic cancer patients.
› Verified 3 days ago